Skip to main content

FDA Drug Recalls

Every FDA drug enforcement recall Public Health Trace has on record, republished from openFDA's official drug enforcement database. See Health Alerts for current, active recalls alongside outbreaks and advisories.

Drug recall information is sourced from the FDA's structured openFDA Enforcement Reports. Newly announced recalls may appear on FDA.gov before they become available in the structured dataset. See Methodology for how Public Health Trace imports and refreshes this data.

Filters
Recall details
Location
Date range
Clear filters

Showing 7,641–7,660 of 17,964 drug recalls

Drug Recall Terminated Historical recordClass III

Accent Care of New York Home Care Nursing Personal Care Hand Sanitizer (Ethyl Alcohol 62%), 0.33 oz/10 mL, OTC, Made in China

by NingBo Huize Commodity Co.,Ltd.

Reason
CGMP deviations: Stability testing was not conducted on manufactured sunscreen and hand sanitizer OTC products.
Recall initiated
April 1, 2019
Reported by FDA
August 7, 2019
Distribution
Foreign manufacturer located in China and distributed to seven consignees located in China.

View recall →

Drug Recall Terminated Historical recordClass II

Keppra (levetiracetam) 1000 mg tablets, 60 tablets per bottle, Rx only, Manufactured for UCB, Inc. Smyrna, GA 30080, NDC 50474-597-66.

by Ucb, Inc

Reason
Failed Dissolution Specifications.
Recall initiated
July 18, 2019
Reported by FDA
July 31, 2019
Distribution
TN

View recall →

Drug Recall Terminated Historical recordClass II

Lisinopril and Hydrochlorothiazide Tablets USP, 20 mg/12.5 mg, 500-count bottle, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202, Manufactured by: Lupin Limited Pithampur (M.P.) 454 775, INDIA, NDC 68180-519-02

by Lupin Pharmaceuticals Inc.

Reason
Presence of Foreign Tablets/Capsules: Product complaint received of one Fenofibrate tablet 145mg observed in 500 s count product bottle.
Recall initiated
July 19, 2019
Reported by FDA
July 31, 2019
Distribution
Nationwide within the United States

View recall →

Drug Recall Terminated Historical recordClass II

LA FRESH travel lite Sunnyside Lotion Wipe silky, non-greasy formula smooth, soft & moisturizing featuring titanium dioxide, 1 wipe individually wrapped packet, 4.75" x 5.75" (12.0 cm x 14.6 cm) Ingredients: Water, Dimethicone, Dimethiconol, Titanium Dioxide, Benzophenone-3, Octinoxate, Ethylhexylglycerine, Phenoxyethanol, Distributed by La Fresh Group, Inc. Chino, CA 91710 www.LaFreshGroup.com

by La Fresh Group, Inc.

Reason
Marketed without an Approved NDA/ANDA: The product may be construed a sunscreen due to labeling of the product and comments about the product found on e-commerce websites.
Recall initiated
July 15, 2019
Reported by FDA
July 31, 2019
Distribution
Firm's website sales and www.Amazon.com

View recall →

Drug Recall Terminated Historical recordClass II

MONSEL'S (Ferric Subsulfate) Solution, 8 mL amber glass bottle, packaged as one dozen bottles with applicators per box, Rx only, Gordon Laboratories, Upper Darby, PA 19082, NDC 10481-0112-8.

by Dercher Enterprises, Inc., DBA Gordon Laboratories

Reason
Microbial Contamination of Non-Sterile Products and Superpotent Drug: FDA analysis revealed microbial contamination in addition to high out of specification results for iron content.
Recall initiated
July 19, 2019
Reported by FDA
July 31, 2019
Distribution
Nationwide in the USA

View recall →

Drug Recall Terminated Historical recordClass II

Preferred Plus Dioctyl Liquid Stool Softener (Docusate Sodium), 50mg/5mL, 16 FL. Oz. (1 PT.) 473 mL, Manufactured by RIJ Pharmaceutical Corp. 40 Commercial Avenue Middletown, NY 10941, Distributed by Kinray Inc. Whitestone, NY 11357, NDC 53807-216-16

by Geritrex, LLC

Reason
cGMP Deviations: Products may have microbial contamination.
Recall initiated
May 31, 2019
Reported by FDA
July 31, 2019
Distribution
U.S.A. Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Gericare Geri-Tussin DM, 16 FL OZ (473 mL), Geri-care Phamaceuticals Corp. 1650 63rd Street Brooklyn, NY, NDC 57896-660-16

by Geritrex, LLC

Reason
cGMP Deviations: Products may have microbial contamination.
Recall initiated
May 31, 2019
Reported by FDA
July 31, 2019
Distribution
U.S.A. Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Ritussin DM Double Strength, 4 FL. OZ. (118 mL), RIJ Pharmaceutical Corporation 40 Commercial Avenue Middletown, NY 10941

by Geritrex, LLC

Reason
cGMP Deviations: Products may have microbial contamination.
Recall initiated
May 31, 2019
Reported by FDA
July 31, 2019
Distribution
U.S.A. Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Preferred Plus Pharmacy Iron Elixir Ferrous Sulfate, 220 mg, 16 fl oz. (473 mL), Distributed by: Geri-care Pharmaceuticals Corp. 1650 63rd Street Brooklyn, NY 11204, NDC 52807-177-16

by Geritrex, LLC

Reason
cGMP Deviations: Products may have microbial contamination.
Recall initiated
May 31, 2019
Reported by FDA
July 31, 2019
Distribution
U.S.A. Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Gericare Iron Supplement Elixir Ferrous Sulfate, 220 mg, 16 fl oz. (473 mL), Distributed by: Geri-care Pharmaceuticals Corp. 1650 63rd Street Brooklyn, NY 11204, NDC 57896-709-16

by Geritrex, LLC

Reason
cGMP Deviations: Products may have microbial contamination.
Recall initiated
May 31, 2019
Reported by FDA
July 31, 2019
Distribution
U.S.A. Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Gericare Diocto Liquid Docusate Sodium Stool Softener, 50 mg/5mL, 16 FL OZ (473 ml), Dist. BY: Gericare Pharmaceuticals corp. 1650 63rd Street Brooklyn, NY 11204, NDC 57896-403-16

by Geritrex, LLC

Reason
cGMP Deviations: Products may have microbial contamination.
Recall initiated
May 31, 2019
Reported by FDA
July 31, 2019
Distribution
U.S.A. Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Ritussin DM Children & Adults, 4 Fl. Oz. (118 mL), RIJ Pharmaceutical Corporation 40 Commercial Avenue Middletown, NY 10941, NDC 53807-409-04

by Geritrex, LLC

Reason
cGMP Deviations: Products may have microbial contamination.
Recall initiated
May 31, 2019
Reported by FDA
July 31, 2019
Distribution
U.S.A. Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Diphenhydramine Oral Liquid Alcohol Free, 12.5 mg/5 mL, 4 fl oz (118 mL), RIJ Pharmaceutical Corporation 40 Commercial Avenue Middletown, NY 10941, NDC 53807-204-04

by Geritrex, LLC

Reason
cGMP Deviations: Products may have microbial contamination.
Recall initiated
May 31, 2019
Reported by FDA
July 31, 2019
Distribution
U.S.A. Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Clobazam Oral Suspension, 2.5 mg/mL, 120 mL bottle, Rx only, Distributed by: Bionpharma Inc., 600 Alexander Road, Princeton, NJ 08540, NDC 69452-116-45.

by Bionpharma Inc.

Reason
Microbial Contamination of Non-Sterile Products: Out-of-specification results for Microbial Enumeration Tests USP <61> was observed.
Recall initiated
July 16, 2019
Reported by FDA
July 31, 2019
Distribution
Nationwide in the USA

View recall →

Drug Recall Terminated Historical recordClass III

Nystatin and Triamcinolone Acetonide Cream USP100,000 units/g, 0.1%, 15 g tube, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202, Manufactured by: Lupin Limited Pithampur (M.P.) 454 775 INDIA, NDC 68180-545-01

by Lupin Pharmaceuticals Inc.

Reason
Failed Content Uniformity Specifications: Out-of-specification result observed in uniformity of containers test at 9 month long term stability condition for upright orientation.
Recall initiated
July 17, 2019
Reported by FDA
July 31, 2019
Distribution
Nationwide within the United States

View recall →

Drug Recall Terminated Historical recordClass II

Hydrocodone Polistirex and Chlorpheniramine Polistirex Extended-Release Suspension, (equivalent to 10 mg hydrocodone bitartrate and 8 mg chlorpheniramine maleate per 5 mL), 16 fl. oz. (473 mL) bottle, Rx only, Manufactured by: Tris Pharma, Inc., Monmouth Junction, NJ 08852, NDC 27808-086-02.

by Tris Pharma Inc.

Reason
Superpotent Drug and Failed Stability Specifications: High out-of-specification results for the active ingredients, hydrocodone and chlorpheniramine, as well as high out-of-specification results for the preservatives.
Recall initiated
July 11, 2019
Reported by FDA
July 31, 2019
Distribution
Nationwide in the USA and Puerto Rico

View recall →

Drug Recall Terminated Historical recordClass III

Methylergonovine Maleate USP 0.2 mg Tablets a) 12 count (NDC 69238-1605-02) and b) 28 count bottles (NDC 69238-1605-08)

by Amneal Pharmaceuticals, Inc.

Reason
Presence of Foreign Tablet/Capsule; one Promethazine tablet was found in a bottle of Methylergonovine Maleate tablets
Recall initiated
July 18, 2019
Reported by FDA
July 31, 2019
Distribution
Product was distributed to three major distributors who may have further distributed the product nationwide.

View recall →

Drug Recall Terminated Historical recordClass II

Atorvastatin Calcium Tablet USP 80 mg, a) 90 count (NDC 67877-0514-90) and b) 500 count (NDC 67877-0514-05) bottles, Rx only, Manufactured by: Alkem Laboratories, Ltd, Mumbai INDIA, Distributed by: Ascend Laboratories, LLC, Parsippany, NJ

by Ascend Laboratories LLC

Reason
Failed Dissolution Specifications
Recall initiated
July 19, 2019
Reported by FDA
July 31, 2019
Distribution
Product was shipped to wholesalers throughout the United States.

View recall →

Drug Recall Terminated Historical recordClass II

0.9% Sodium Chloride Injection USP, 100 mL Viaflex Container, Rx Only, Baxter Healthcare Corporation, Deerfield, IL 60015, USA, NDC 0338-0049-38.

by Baxter Healthcare Corporation

Reason
Lack of Assurance of Sterility: Bags have potential to leak.
Recall initiated
July 18, 2019
Reported by FDA
July 31, 2019
Distribution
Nationwide in the United States and Puerto Rico.

View recall →

Drug Recall Terminated Historical recordClass II

Temozolomide Capsules, 250 mg, 5-count bottle, Rx only, Manufactured by: Deva Holding A.S., 1 Merkez Mahallesi, Istanbul, Turkey 34303, Distributed by: Ascend Laboratories, LLC, Parsippany, NJ 07054, NDC 67877-542-07.

by Deva Holding AS - Cerkezkoy Subesi

Reason
CGMP Deviations: product was manufactured that did not prevent possible cross contamination with beta lactam products.
Recall initiated
July 16, 2019
Reported by FDA
July 31, 2019
Distribution
Nationwide in the USA.

View recall →

Data last updated:

This information is republished from FDA's Recall Enterprise System through openFDA. Public Health Trace does not verify or supplement it, is not affiliated with the FDA, and does not provide medical advice -- always follow the guidance of your pharmacist, physician, or the recalling company for any medication you take. Read the full medical disclaimer.